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Immunity in relapsing fever has been under  investigation since  1906  (1,  2), 
but the mechanism of this immunity is poorly understood.  This is because of 
the  instability of  Borreliae,  the  scanty  information  on  the  genealogy of  the 
strains  used,  the  wide  range  of  experimental  animals  studied,  the  lack  of 
quantitative  data on  the  infective doses,  and  the  crudity of  the  qualitative 
serological tests (3-5). 
The present study was undertaken in an effort to elucidate the mechanism 
of the crisis phenomenon.  Blood was studied in an attempt  to determine the 
nature of the factor(s) which might be responsible for resolution of the primary 
infection. This necessitated the development of an appropriate method for the 
production of assayable infections, so that the result of treatment with serum, 
plasma, or their derivatives, obtained at the time of crisis, might be determined 
reliably. 
Material and Methods 
Maintenance of the Strain.--The strain of Bovrdia novyi  I used was maintained in 21-day-old 
rats (Hisaw strain) weighing an average of 45 gin. These served for the experimental studies 
as well as for maintenance  of the strain. For this latter purpose several drops of blood were 
taken by cardiac puncture from infected donor rats under light ether anesthesia into syringes 
containing 1 ml. of a high phosphate buffer (v/de infra)  and injected into recipients.  This was 
done intraperitoneaily at biweekly intervals. 
Blood fur preparation of quantitative inocula was obtained by cardiac puncture from in- 
fected rats under fight ether anesthesia  2 at 60 to 65 hours after infection had been instituted. 
* This investigation was supported by a grant from the Milton Fund, Harvard University. 
It was started under the sponsorship  of a Harvard School of Public Health Fellowship and 
was completed  with the aid of Research  Fellowship  No.  EF-5766-C  from the Division of 
Research  Grants of the National Institutes of Health, United States Public Health Service, 
Bethesda, Maryland. 
a I wish to thank Dr. Quentin M. Geiman for the supply of this strain which was obtained 
in 1946 from Dr. Malcolm H. Soule of the University of Michigan,  Ann Arbor. This strain, 
originally isolated in 1906 from the first case of relapsing fever on record in this country (6) 
and maintained since then in rats and white mice, is believed to be identical with Spirochaeta 
obermeieri (2). 
2 Ether anesthesia does not affect the  course of B.  novyl  infection  in  experimental ani- 
mals (7). 
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Blood was drawn into syringes containing 0.3 ml. of a  heparinized Ringer's solutiona per i0 
ml. of blood.  These bloods were pooled and diluted  1:200 with a  sterile phosphate buffer 
devised by McKee  and  Geiman (8), which facilitates longer survival of the organisms by 
virtue of added glucose (9) and a higher than usual concentration of phosphate (7).5 
0.005 ml. of the diluted blood was delivered on a  clean slide beneath an 18 x  18 sq. mm. 
coverslip. The organisms were counted with a dark-field microscope, calibrated according to 
standard  technic,  and  provided  with  wide-field  oculars  and  oil immersion objective.  The 
number of spirochetes per oil field was taken from the average of four 0.005 ml. preparations, 
and from this number the number of spirochetes/c.mm, of diluted blood was calculated. The 
counts indicated that from 0.15 to 0.25 ml. of the diluted freshly drawn blood would be needed 
to provide an infective dose of 1 ×  108 spirochetes/kg. The required volume was brought to 
a  final volume of 0.4 ml. with the phosphate buffer, and was then injected intraperitoncaUy 
into recipient rats. All procedures relating to the preparation of the quantitative inocula were 
carried out at 4°C. 
E~aluagon of Spirochetemla.--The course of the infection was determined in terms of the 
number of circulating spirochetes per cubic millimeter of blood at varying intervals after the 
inoculation as follows: Films of heart blood or tail venous blood were made and stained with 
Giemsa according to standard procedure. Thick films were prepared if dark-field inspection 
showed the number of organisms to be 1 per 1000 red cells or less. Thin films were prepared 
when the number was above this ratio. When the count in stained thick films was less than 
one spirochete per 100 white blood cells,  the number of organisms per 600 white blood cells 
was determined. When the count was more than one spirochete per 100 white blood cells,  the 
number per 200 white blood cells was determined. When no organisms were seen in counts of 
600 white blood cells in consecutive fields (two readings per film), blood was considered nega- 
tive. 
Counts in stained thin films were made by Reed's method (I0, 11),  originally devised for 
the enumeration of malarial parasites in avian blood films. By using this method suificient 
organisms and red cells are counted so that the probable error in evaluating the smears does 
not exceed 10 per cent. 6 
Because of the progressively severe anemia in  this disorder (~4de infra), calculation  of 
spirochetal count per c.mm. of circulating blood required a redetermination of the red count 
each time a film for a spirochetal count was prepared. 
EXPERIMENTAL 
The Dose Response in Experimental Infection.- 
In preliminary attempts to establish an infective dose of choice, inoculations in excess of 
6  X  10  s organisms/kg, produced  too severe a  spirochetemia to permit an accurate count. 
Study of the effect of smaller, graded infective doses (1  ×  108, 1 ×  10L  1 ×  104) showed a 
decrease in the levels of spiroehetemia and a  delay in the onset and termination of the crisis 
a 125 rag. of sodium heparin (v.s.P. 150 units/rag. 11.1 per cent H20, General Biochemical 
Co.)  was dissolved in 25 ml. of modified Ringer's solution: NaC1 0.821  gin., KCI 0.3  gin., 
CaClv 2H20 0.27 gin., MgClv 6H~O 0.1 gin., and aq. dist. to 103 ml., pH 7.0-7.2, and sterilized 
by autoclaving. 
~Na!-I2HO4.H~O  0.7596 gin.,  Nw2HPO4 3.1240  gin., NaCI  1.9685  gin.,  KC1  0.2050  gin., 
MgClv6H20 0.0475 gin., CaClv2H20 0.0371  gin., 32 rag.  per cent solution of MnClv4H20 
0.5 ml., and distilled water to 500 ml. This buffer (pH 7.2) is isotonic with blood and is ster- 
ilized by autoclaving. 10 ml. of 10 gin. per cent solution of glucose in distilled water is added 
aseptically to give a final concentration of 200 rag. per cent glucose. 
5 The validity of Reed's formula for spirochetal counts has been verified (12). ORNELLA CALABI  813 
phenomenon in proportion to dose (Table I). An inoculation of 1 X  108 spirochetes/kg, proved 
to be the optimal infective dose. With this dose the acute phase was relatively short and the 
spirochetemia could be quantitated with desirable accuracy. Observations on the course  of 
untreated infections with this infective dose over a period of 18 mouths may be summarized 
as follows: (a) the primary infection lasts about 5 to 6 days, with the highest spirochetal count 
at about 72 hours (4 to 5 million/c.mm, blood); (b) crisis ends between 110 and 155 hours 
after inoculation; (c)  the red blood cell count falls to  1.0 to  1.89 X  10  e rbc/c.mm, blood  6 
TABLE I 
The Ez~ecl of Graded Doses of Spirochetes on the Intensity and Durcaion of B. novyi infection 
Log No. of spirochetes/c.mm,  blood* 
Spirochetal dose/kg.~. ~  _[ 
Rat No ................. 
]ff$. 
13 
Group  1 
I X  101 
3.2  3.4 
Group  2 
I  X 10 ° 
-oo~ 
8  I 
Group 3 
I XIO 4 
9  10 
38 
67 
72 
84 
116 
134 
139 
157 
4.7 
6.4 
6.6 
6.5 
--aO 
--o0 
5.1 
6.6 
6.7 
6.6 
--o0 
--oO 
2.9 
4.8 
5.7 
5.9 
5.6 
ND§ 
3.3 
5.2 
5.4 
5.9 
5.3 
ND 
5.6 
--O0 
D00 
3.1 
4.0 
4.2 
3.8 
ND 
3.5 
--a0 
--oo 
2.7 
3.1 
4.1 
3.4 
ND 
iO0 
--O0 
* Blood samples from peripheral blood. 
No spirochetes (the log of zero is -  oo). 
§ No data. 
(12);  (d)  relapse starts from 30 to  70 hours after resolution of the primary infection. The 
highest count observed during the relapse (20 to 10,000 spirochetes/c.mm, blood) were 5 X 
10  "~ to 2.5 X  10-~ that of the primary infection. The duration of the relapse is usually 3 to 5 
days, with maximal counts occurring from 1 to 4 days after its onset (12). 
Since the response to a  1  ×  108 dose was reasonably constant after repeated 
trials,  we  considered  that  this dose  would provide  crisis serum at  about  100 
hours  after  inoculation. Such  serum  was  used  for  treatment  of  the  primary 
infection in rats inoculated with 1 X  10  s organisms. 
Bio-assay  of  Crisis  Serum.--Mter  preliminary  quantitative  assays  had 
suggested an appreciable inhibitory effect of crisis serum on the course of the 
induced infection, the following study was made. 
6 The normal range in the red blood cell counts in the rat has been variously reported to be 
7.2 to 9.6 (13), 6.60 4- 0.76 (14), 8.50 4- 1.50 (14). 814  PLASMA  INHIBITORS  IN  RELAPSING  FEVER 
Thirty weanling rats were divided into three groups of ten each. Each rat received 1 X  108 
spirochetes/kg, at 0  hour. One hour later those in Group  1 were treated with 10 ml./kg, of 
crisis serum. Those in Group  2 received 10 ml./kg, of normal serum. Those in Group 3  re- 
ceived no treatment. Two animals from each group were killed simultaneously at varying in- 
tervals after inoculation to provide heart blood  T for determination of the spirochetemia. 
TABLE  II 
The Effe*t of Crisis Serum and Normal Serum on the Course of B. novyi Infection 
Spxrochetal  dose/kg ..... 
Serum treatment, 
10 ml./kg  ............. 
Time 
IllS. 
54 
78 
Group 1 
1 X  IO  s 
Crisis serum 
Rat  No  Log spiro* 
1.8 
--oo 
1.8 
I 
Group 2 
106 
130 
183 
0.9 
3.9 
--oo 
1.6 
--oc 
11 
12 
13 
14 
15 
16 
17  t 
18 
19 
20 
IXIO a 
Normal serum 
Rat  No.  Log spiro 
21  6.2 
22  6.3 
23  6.8 
24  -  oo 
25  3.9 
26  3.9 
27  -- o, 
28  -  o, 
29  1.4 
30  6.1 
Rat No. 
31 
32  ! 
33 
34 
35 
36 
37  I 
38  , 
I 
39  ~ 
i  i 
Group  3 
IXIO a 
None 
Log spiro 
6.08 
6.01 
6.4 
6.6 
5.6 
--at) 
--oO 
--:O 
4.1 
0.9 
* Log number of spirochetes.c.mm, heart blood. 
:~ No spirochetes (the log of zero is -- oo). 
Inspection of Table II shows  that  during  the phase of active growth  the 
spirochetemia was  of about  the same intensity in  Groups 2 and 3,  while in 
Group 1 there was no spirochetemia or one of far less intensity; i.e.  from 10 -5 
to 10  -6 that of the control group. 
These data demonstrate the presence of inhibitors of the infection in crisis 
serum,  and that  this inhibition remains effective throughout an observation 
period lasting from 78 to 130 hours. 
7 Spirochetal counts from samples of heart blood were 25 to 40 per cent higher than counts 
from samples of tail blood. Analogous observations have been made in experimental malaria 
(7). Films from peripheral blood, nevertheless, were taken as well because they made possible 
the handling of all animals before being sacrificed. The differences between heart and peripheral 
blood do not appear in the table. ORNELLA  CALABI  815 
Biological Standardization of Crisis Plasma.--The next step was an effort to 
evaluate  the protective titer of whole plasma and of fractions of plasma.  The 
study was made with plasma instead of serum because plasma is as potent as 
serum (12), can be obtained in greater yield, and lends itself better to fraction- 
ation procedures (15). 
Crisis blood was harvested from groups of 16 to 24 donor rats, which were bled by cardiac 
puncture  from 91 to 93 hours after  inoculation of 1 )<  l0  s spirochetes/kg.  The blood was 
heparinized as described above, and centrifuged at 4°C. for 1 hour. The pooled plasma was 
sterilized by passage through an ultrafine fritted glass filter at 4°C., and then diluted in phos- 
phate buffer so as to provide  1:64,  1:16, and 1:4 dilutions.  Five groups of four rats each 
TABLE III 
The E.~ea of Increasing Doses of Crisis Plasma on the Course of B. no~yi Infection 
Log No. spirochetes/c.mm, blood* 
Group  NO...  I  i  2  3  4  [  5 
Crisis 
plasma 
treatment, 
10 nd.ltg.  . 
Rat No. 
x:.  j  t:16  j 
61  i 62  63  64  65  66  67  68  69  70 
Time  --  --I  ...... 
]w$. 
13  3.2  2.9[--ml  2.9  2.91 2.7  2.21 2.7  2.7/-~o 
37  4.5  4.6[  1.3  48  48  44  41146  45--~0 
76  6.4  6.4  0.9  6.8  6.7  6.2  5.5  6.5  1.2  2.5 
....  38  .... 
•  155  --~o  --~[  3.6  --~,  --oo  --~o  --~  --~  --~e  --,:e 
I 
I 
1:4  l 
71  [ 72  73  74 
iili 
1:1 
75  76 
woo  -oo 
--or  -oo 
--ao  -oo 
3.7  --~ 
2.C  1.2 
None 
77  78  79  i 80 
-_-2- 
2,333,  32 
39  48148148 
6.6  6.5[  6.71 6.5 
6.2  5 7[--~o --~ 
....  i-~!-~ 
* Blood samples from peripheral blood. 
:~ No spirochetes (the log of zero is -~  ). 
received the infective dose of spirochetes (1 X  los/kg.).  Four of the five groups were injected 
intraperitoneaUy  with  10 ml./kg,  undiluted  plasma,  or with one of the  three  dilutions  of 
plasma. The fifth group received no plasma and served as a control. 
The results  (Table  III) show that crisis plasma diluted  1:4, as well as un- 
diluted  plasma,  has a  high protective effect, with maximal spirochetal counts 
at 120 hours after treatment of 10  -3 to 10  -e that of the control group (group 5). 
No suppression of spirochetemia occurred with crisis plasma of higher dilution. 
The efficiency of the  graded dose bio-assay in  the  standardization of crisis 
plasma  is readily evident  when  the  log of spirochetes/c.mm,  blood is plotted 
as a function of the log dose of crisis plasma given (Fig.  1). The dose-response 
at 37 and at  76 hours after treatment  (Fig.  1)  reveals a  significant difference 
in  spirochetemia  between  the  protected  (1:4  dilution)  and  the  unprotected 
(1:16 dilution)  groups. This range in dilution is the protective titer according 
to the criterion for biological standardizations. 816  PLASMA INHIBITORS IN RELAPSING ~FEVER 
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Statistical  Analysis.--The  results  obtained  from  the  biological  standardi- 
zation of  crisis plasma were  evaluated by the  method  of  appropriate  scores 
for linear bio-assays (16) to ascertain how much of the total variance in spiro- 
chetal counts can be explained by the protective dose of crisis plasma given. 
This fraction of the over-all score system in function of the dose of crisis plasma 
given is called the information (16). 
Computation of appropriate scores  throughout the  course of  the  infection  s 
(Table  IV)  shows  that  the  maximum information obtained from  dose  and 
scores at  13,  37, and 76 hours is significant when the  x~ test  (16)  is  applied. 
TABLE IV 
Appropriate Scores (16) in the Biological Standardization of Crisis Plasma 
cSp:r°m-ia  Total No. [Xak(x'-- ~,)2~ 
level at*  of rats  __ 
hrs.  I 
13  I  16 
37  16 
76  16 
120  16 
Appropriate 
scores§ 
Xi  (di)~ 
a.i. 
80  38.5 
80  59.1 
80  53.0 
80  14.4 
Info 
matio 
per c~ 
48.1: 
73.8 
66.2. 
18.0 
Significance of a..O¶ 
2  xc =  a..O =  7.68 (DF =  2) 
0.02<P< .05 
2  xc =  a..O =  11.82 (DF =  2) 
0.001 <P< .01 
2  x, =  a..O =  10.6 (DF =  4) 
0.02<P< .05 
2  xc =  a..O =  2.88 (DF =  2) 
0.20<P< .30 
* Time in hours after inoculation of 1 X  10  8 spirochetes/kg, followed by administration of 
10 ml./kg, of crisis plasma at the appropriate dilution. 
:~ Sum of squares of deviations in response independent of crisis plasma dose given. 
§ Sum of squares of deviations in response in function of crisis plasma dose given. 
II Fraction of total variance in spirochetal counts in function of crisis plasma dose given. 
¶  Maximum information extracted from dose and scores. 
It will be noted that at 37  hours the score  system shows  the best  fit with a 
larger x~c value (x2c =  11.82), and with an associated probability of  less  than 
1 chance in 100 that the maximum information extracted from dose and scores 
(73.875  per cent)  is due  to  chance variation (0.001  <  P  <  0.01).  It follows 
that the 37 hour readings under the specified conditions are the most significant 
and provide us with the maximum information from dose and scores. 
Fractionation  Procedures.--Following  the  demonstration of  the  potency of 
crisis plasma an effort was made to identify the fraction or fractions of plasma 
8  The essential data  on the  intensity of the infection under the  specified conditions are 
taken from Table III. 818  PLASMA  INHIBITORS  IN  RELAPSING  FEVER 
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which  contain  the  inhibitor(s).  Fractionation  was  done  within  4  hours  after 
collection of the blood as follows :-- 
Pooled, heparinized crisis plasma from 24 donor rats was treated  by method 10 of Cohn 
eta!.,  (17,  18)  to  the  end  of  the  first  step,  which  yields  the  two  main  fractions 
(I  -4-  II  -4-  HI  and  IV  +  V  -4-  VI).  Fractional  precipitation  was  carried  out  in 
a  -5°C. agitated bath containing 20 per cent ethylene glycol by adding one volume of crisis 
plasma  to four volumes of reagent solution  (18)  freshly prepared  from 95 per cent ethanol 
water and stock solution of c.p. sodium acetate buffer.  The precipitate (I -J- II A- III), con- 
TABLE V 
The Effect of Crisis Plasma and of Fractions I  +  II +  III and IV +  V +  Vl from Crisis 
Plasma (CP) on the Course of Bor. nozyi Infection 
Group No. 
Spiro- 
chetal 
dose/kg. 
Crisis 
plasma 
treat- 
ment, 
1o raLIk~ 
~$. 
26 
51 
76 
120 
Log No. of spirochetes/c.mm, blood* 
I 
I XIO~ 
I  +  II +  III 
Rat No...  41  [ 42  43  44 
/ 
Time  [ 
I 
--ao~  --no 
--no  --~ 
0.9  3.4 
I X  I0  s 
Iv+ v +  vI 
45  46  47  48 
1X10 i 
CP -55°C. 
49  50  51  52  53 
I XIO 8 
CP 4°C. 
36 
--co  --Qe 
--ao  --m 
-~  ~§ 
4.0  ND 
-oo  -~ 
0.9  -~o 
2.6 --~e 
--ee  3.1 
--co  3.9 
1.~  4.8 
2.C  3.0 
~oo  --oo 
--oe  --ca 
--oo  --~ 
3.0 --~  3.513.0 
k~ 
--¢@ 
54  55  57 
I 
I  -~e-en-:e  4.2 
-~-~-~  5.9 
--~I--~--~  6.7 
0.9  0.~1--~  2.81--:e 
5 
I 
i  I XIO 6 
i 
None 
58  59  60 
4.~  4.,  4.0 
6.C  5A  6.0 
6,~  6.~  6.7 
$,~  4. (.  2.3 
* Blood samples from peripheral blood. 
:~ No spirochetes (the log of zero is --ao). 
§ No data. 
taining the gamma globulin fraction, was separated from the supernatant  (IV A- V A- VI), 
containing the albumin fraction, by centrifugation at 4000 r~.P.g, at  --5°C. for 30 minutes. 
The two main fractions were dried from the frozen state and were dissolved to plasma volume 
for electrophoretic analyses and  bio-assays.  The protein concentrations of fraction I  A- II 
+  III and fraction IV A- V +  VI from 50 ml. of pooled plasma dissolved to plasma volume 
were 1.181 gin. per cent and 4.377 gin. per cent, respectively. 
Electrophoretic Procedure.-- 
Dried fractions were weighed out and  dissolved in barbiturate  buffer  (pH 8.6,  r/2  0.1 
sodium  diethyl barbiturate),  clarified by centrifugation for 30 minutes  at  18,000 ~.P.~.  at 
4°C., resuspended to plasma volume in the barbiturate buffer and applied to the origin line 
of paper strips. A sample from normal rat plasma was included. The strips, after treatment 
with different ranges of plasma protein concentration (0.01 ml., 0.02 ml., and 0.03 ml.), were ...............  TREATED 
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saturated with barbiturate buffer and inserted into the apparatus.' The apparatus and its 
contents were allowed to equilibrate for at least 1 hour. Runs were completed after 18 hours 
at 4°C. with voltage adjusted (5.5 ma., 200 volts). The strips were then removed, dried, stained 
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FIG. 3.  Effect of crisis plasma (CP) stored 24 hours at  -55°C. on the course of B. novyi 
infection in rats. The solid curve represents the course of the untreated infection (counts are 
averages from four animals, see data in Table V). The broken line curves show the course of 
the infection in three rats which received this plasma 2 hours after inoculation of spirochetes. 
The curves show that the maximum suppressive activity of frozen CP lasts from 76 to 140 
hours and compares well with the activity of plasma stored 24 hours  at 4°C.  (see data in 
Table V) and with the activity of fresh undiluted CP (see data in Table III). 
by immersing them for 15 to 20 minutes in a saturated solution of naphthol blue black  1° in 
10  per  cent  acetic  acid  and  3  per  cent  phenol,  rinsed  in  10  per  cent  acetic  acid 
and 3 per cent phenol, and allowed to dry at room temperature. 
g The apparatus used for electrophoresis was patterned after that of Latner (19). 
10 Howe and French, Inc., Laboratory Supply Division, Boston. OlIN'ELLA CALABI  821 
Results of Fractionation Studies.-- 
Electrophoretic  analyses  (Fig.  2)  demonstrated  the  absence  of  gamma 
globulin in  fraction  IV  +  V  +VI.  Conversely,  no  albumin  was  present  in 
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FIO. 4.  The effect of fraction I  +  II +  III from crisis plasma on the course of B. ngvy/ 
infection in rats. The solid curve represents the course of the untreated infection  (counts are 
average counts from four animals, see data in Table V). The broken line curves show the course 
of the infection in three rats which received this fraction 2 hours after inoculation of spiro- 
chetes. They show that this fraction suppresses the infection for 76 hours. 
fraction  I  +  II  +III.  As in human  plasma,  proteins with  the mobility of 
beta globulins were found in both fractions. Although some of the alpha  glob- 
ulins  in  human  plasma  are known to be destroyed by  drying fractions from 
the  frozen  state,  a  component  with  the  mobility of alphas globulins  (glyco- 
proteins) was present in fraction IV +  V  -I- VI as a  distinct band. 822  PLASMA  INHIBITORS  IN  RELAPSING  FEVER 
Bio-assay of Whole Plasma,  Fractions I  -Jr II +  III and Fractions IV + 
V+VI.-- 
The dried frozen fraction IV q-  V  +  VI was resnspended to plasma volume in distilled 
water. The dried frozen fraction I q- II +III,  containing no salts, was resuspended to plasma 
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FIG. 5.  The effect of fraction IV +  V  +  VI from crisis plasma on B. no~y/infection in 
rats.  The solid curve represents the course  of the untreated  infection (counts are average 
counts from four animals, see data in Table V). The broken line curves show the course of 
the infection in three rats treated with this fraction 2 hours after inoculation of spirochetes. 
They show that the magnitude of the spirochetemia is reduced and that the dday in its onset 
is of variable length, up to a maximum of 76 hours. 
volume in phosphate buffer to provide a  solution hotonic with blood. These  fractions were 
centrifuged at 4°C.  for 30 minutes at  18,000  R.P.M. for the removal of denatured  proteins 
which might be present. Dialysis, therefore, was not considered necessary. 
Twenty weanling rats were divided into five groups of four animals each. At 0  hour all 
received the infective dose of 1 X  108 spirochetes/kg. Two hours later groups 1 and 2 received 
10  ml./kg,  of  fraction  I  +  II  +  III  and  fraction  IV  +  V  +  VI  respectively, ORNELLA  CALABI  823 
dissolved to  plasma  volume and sterilized by  filtration through an  ultrafine fritted  filter. 
Group 3 received the same dose of whole plasma, which had been quick frozen and stored at 
-55°C.  for 24 hours as a  control for the effect of freezing, which is a  step in fractional pre- 
capitation. Group 4 received whole plasma, stored at 4°C. for 24 hours. Group 5 received no 
plasma and served as control for the infection. 
The results show that freezing to --55°C.  did not destroy the inhibitor(s), 
because the suppressive activity of such plasma preparations persisted from 
3 to 6 days after injection (Table V, column 3, and Fig. 3), and compares well 
with the activity of plasma stored 24 hours at 4°C. (Table V, column 4) and 
with the activity of fresh undiluted crisis plasma (Table III, column 4). 
Both fractions were also effective in suppressing  the acute spirochetemia, 
but  differed in duration and effectiveness (of.  Fig.  4  with Fig.  5).  Fraction 
I  +  II -4-  III was about as effective as whole plasma, for the infection was 
suppressed  for 76  hours and at  120  hours  the spirochetal counts were only 
10 to 104/c.mm.  (cf.  Table V, column 1, with Table III, column 4).  Fraction 
IV  +  V  -4-  VI was less effective, for spirochetes were demonstrable after 14 
to 97 hours; but maximal counts were from 10  -2 to 5 ×  10  -3 the count of the 
controls.  In terms  of potency relative  to  plasma,  this  fraction at  76  hours 
was roughly equal to a 1:4 dilution of whole plasma (cf.  Table V, column 2, 
with Table III, column 3). 
DISCUSSION 
To our knowledge this study demonstrates for the first time the presence in 
plasma of the rat at the time of crisis of spirochetal inhibitor(s) which delays 
the onset of the spirochetemia for at least 76 hours, and reduces its intensity. 
It is present in fraction I +  II +  III in greater potency than in fraction IV + 
V  +  VI. Since proteins with the mobility of beta globulins did occur in both 
fractions, their role deserves more attention in the further study necessary to 
identify the nature of the inhibitor(s). 
If the inhibitor(s) is an antibody it is remarkable that the rat should be able 
to develop it within 76 hours after inoculation of the spirochetes. 
SUM~A.Ry 
The intensity  and duration of Borrelia  novyi  infection  in rats  depends upon 
the dose of spirochetes administered. The spirochetemia in response to an 
inoculum of 1 X  I0  s  spirochetes/kg,  characteristically  reaches a peak of 4 to 5 
million organisms per c.mm. of blood at about 72 hours. Resolution of the 
primary infection  occurs within 48 hours after the peak counts have been 
observed, with crisis  ending at 100 to 120 hours after  inoculation. 
Treatment of the acute infection,  so standardized, by 10 ml./kg, of crisis 
plasma intraperitoneally  delays the  onset of  the  spirochetemia 76 to 140 hours, 
and reduces the  maximal spirochetal  count 10  -3 to 10  -6 that of the unmodified 
controls.  This is  evidence that inhibitor  is  present in the plasma at  the time of 
crisis  and plays  a role  in  limiting  the  primary infection  and subsequent relapses. 824  PLASMA INHIBITORS  IN RELAPSING FEVER 
The activity of crisis plasma is not destroyed by freezing, or after storage at 
4°C. for4 days. Fractions I  -t- H  +  III andlV -b Vn  u VI from crisis plasma, 
obtained by method  10 of Cohn et al., were also effective in suppressing  the 
acute  spirochetemia,  but  differed in  duration  and  effectiveness. The first of 
these was about as potent as the undiluted whole plasma, and the second about 
as potent as plasma diluted  1:4. 
The author is indebted to Dr. Douglas M. Surgenor, Department of Biophysical  Chemistry, 
Harvard  Medical School, for valuable suggestions and advice in plasma fra~fionation pro- 
cedures, and to Dr..Tane Worcester, Department of Biostatisfics, Harvard School of Public 
Health, for assistance in statistical analysis and interpretation of figures. 
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